SCHEMBL120212

SCHEMBL120212

NC(=O)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL937615 1.00
Hydrochloric Acid SCHEMBL3194035 0.98 CES2 (0.62)
Hydrochloric Acid SCHEMBL485645 0.98
Urea SCHEMBL4239865 0.98 CES2 (0.62)
Cyclopentane SCHEMBL29102054 0.93 CES2 (0.58)
Sulfuric Acid SCHEMBL28129454 0.91 CES2 (0.56)
Phosphoric Acid SCHEMBL28129466 0.91 CES2 (0.56)
Formic Acid SCHEMBL17065262 0.91 CES2 (0.56)
SCHEMBL30385820 0.91 DAO (0.58)
Isopropylamine SCHEMBL28222054 0.89 RAB9A (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6319 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121673323-B Sulfide ore collecting agent based on thiophene-amide-sodium phosphate salt, and preparation method and application thereof CHANGCHUN GOLD RESEARCH INSTITUTE Co.,Ltd. (CN) 2026-05-26 CN claimed
EP-3346842-B1 STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME NOVONESIS PLANT BIOSOLUTIONS AS (DK) 2026-03-25 EP claimed
US-20260070879-A1 ISOXAZOLINE DERIVATIVES ELANCO TIERGESUNDHEIT AG (CH) 2026-03-12 US claimed
US-12497370-B2 Isoxazoline derivatives ELANCO TIERGESUNDHEIT AG (CH) 2025-12-16 US claimed
US-20250361244-A1 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS AURIGENE ONCOLOGY LTD (IN) 2025-11-27 US claimed
US-20250318532-A1 ASCAROSIDE COMBINATIONS ASCRIBE BIOSCIENCE INC (US) 2025-10-16 US claimed
EP-4618758-A1 MIXTURES OF SUCCINATE DEHYDROGENASE INHIBITORS AND PICOLINAMIDES FMC Corporation (US) 2025-09-24 EP claimed
CN-120202200-A Oxo-isoindolinyl substituted tetrahydropyrimidinedione-based compounds and applications thereof 标新生物医药科技(上海)有限公司 2025-06-24 CN claimed
EP-4008329-B1 ISOXAZOLINE COMPOUNDS FOR USE IN TREATING DEMODICOSIS INTERVET INT BV (NL) 2025-06-11 EP claimed
CN-114763346-B Compounds for inducing cartilage formation and application thereof 华东师范大学 2025-06-10 CN claimed
EP-0346511-A1 Oxygen-containing hererocyclic compound, processes for their preparation and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-12-20 EP claimed
US-4870075-A AGRICULTURE IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-09-26 US claimed
US-4791112-A ANALGESICS, NAQRCOTIC ANTAGONISTS THE BOC GROUP, INC. (US) 1988-12-13 US claimed
CN-88100563-A N-heterocycle-N-(4-piperidyl) acid amides and the constituent of medicine and the application method of this compounds 1988-08-17 CN claimed
EP-0249236-A1 N-1H-Tetrazol-5-yl-(5-Ring)-carboxamide-derivatives, a process for their manufacture, and the use thereof WARNER-LAMBERT COMPANY (US) 1987-12-16 EP claimed
US-4684731-A NEUROLEPTIC, ANTIEMETIC, ANALGESIC HOFFMANN-LA ROCHE INC. (US) 1987-08-04 US claimed
US-4643849-A ANTIULCER, ANTISECRETORY AGENTS TOYAMA CHEMICAL CO., LTD. (JP) 1987-02-17 US claimed
EP-0037990-B1 PHENYL QUINOLIZIDINES, CORRESPONDING PHARMACEUTICAL PREPARATIONS, THE PREPARATION OF THE ACTIVE COMPOUNDS AND CORRESPONDING STARTING COMPOUNDS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-12-05 EP claimed
EP-0022494-B1 BETA-LACTAM-COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1983-02-23 EP claimed
EP-0037990-A1 Phenyl quinolizidines, corresponding pharmaceutical preparations, the preparation of the active compounds and corresponding starting compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-10-21 EP claimed